Latest Puma Vct IV Plc (PUMD) Headlines ProUr
Post# of 4
Posted On: 03/11/2014 2:57:57 AM
Latest Puma Vct IV Plc (PUMD) Headlines
ProUroCare Announces Changes to Management and Board of Directors
Business Wire - Mon Apr 29, 8:00AM CDT
ProUroCare Medical Inc. (OTCQB: PUMD) is pleased to announce the appointment of Stan Myrum as Interim CEO of the company and as a Director on its Board of Directors. Stan has over 30 years of medical device experience with Medtronic where he provided executive leadership in Operations, Supply Chain, Quality, Regulatory, Clinical and Product Development. In addition, he was Medtronic's Vice President of Operations and Technology for Europe, Middle East and Africa for six years. Since his retirement from Medtronic in 2007 Stan has provided consulting services to medical device start-up companies (including ProUroCare) as well as conducting due diligence for medium to large venture capital and medical device companies. Myrum stated, "I am very excited about this opportunity to lead the commercialization efforts for this exciting prostate imaging technology in a field of such significant unmet medical needs."
ProUroCare Announces Changes to Management and Board of Directors
Business Wire - Mon Apr 29, 8:00AM CDT
ProUroCare Medical Inc. (OTCQB: PUMD) is pleased to announce the appointment of Stan Myrum as Interim CEO of the company and as a Director on its Board of Directors. Stan has over 30 years of medical device experience with Medtronic where he provided executive leadership in Operations, Supply Chain, Quality, Regulatory, Clinical and Product Development. In addition, he was Medtronic's Vice President of Operations and Technology for Europe, Middle East and Africa for six years. Since his retirement from Medtronic in 2007 Stan has provided consulting services to medical device start-up companies (including ProUroCare) as well as conducting due diligence for medium to large venture capital and medical device companies. Myrum stated, "I am very excited about this opportunity to lead the commercialization efforts for this exciting prostate imaging technology in a field of such significant unmet medical needs."
(0)
(0)